MedTrace Logo

Clinical Evaluation of Bacitracin

NCT00132600 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2005-10-19

No results posted yet for this study

Summary

The purpose of this study is to establish a concentration of a bacitracin-patch for diagnosing allergic contact dermatitis.

Conditions

  • Allergic Contact Dermatitis

Interventions

DRUG

bacitracin (allergen)

Sponsors & Collaborators

  • Mekos Laboratories AS

    lead INDUSTRY

Principal Investigators

  • Joseph Fowler, Prof. · Mekos Laboratories AS

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
DOUBLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-04-30
Completion
2005-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00132600 on ClinicalTrials.gov